EHMT2 and neoplasm: In cancer, G9a is upregulated in a variety of neoplasms, including lung, colon, ovarian, oesophageal squamous cell and hepatocellular carcinomas, and correlates with tumor aggressiveness and poor patient prognosis 10,12-16.